Azienda Ospedaliero-Universitaria Careggi-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    The Lancet, Vol. 401, Núm. 10373, pp. 269-280